Celera Corporation (NASDAQ:CRA) announced today that it will webcast its
presentation at the 20TH Annual Piper Jaffray Healthcare
conference on Tuesday, December 2, 2008. The live webcast is scheduled
to begin at 1:30 p.m. ET when Kathy Ordoñez, Chief Executive Officer of
Celera, will provide a brief overview of Celera’s business, followed by
a question and answer session with investors and a Piper Jaffray
financial analyst.
Interested parties may access the live webcast and replay by visiting
the Investors & Media section of the Celera website at www.celera.com.
It is suggested that participants access the webcast 15 minutes before
the start of the live broadcast. The webcast replay will be archived on
the Presentations page of the Investors & Media section of website.
About Celera
Celera is a healthcare business delivering personalized disease
management through a combination of products and services incorporating
proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera,
offers services to predict cardiovascular disease risk and improve
patient management. Celera also commercializes a wide range of molecular
diagnostic products through its strategic alliance with Abbott and has
licensed other relevant diagnostic technologies developed to provide
personalized disease management in cancer and liver diseases.
Information about Celera Corporation, including reports and other
information filed by the company with the Securities and Exchange
Commission, is available at http://www.celera.com.
Copyright© 2008. Celera Corporation. All Rights Reserved. Celera is a
registered trademark of Celera Corporation or its subsidiaries in the U.
S. and/or certain other countries.
Celera Corporation
David Speechly, Ph.D., 510-749-1853
David.Speechly@celera.com
